Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1960 Sep 24;83(13):690–695.

Guanethidine Administration in 28 Hypertensive Patients *,†

G Pigeon, Jean Davignon, Pierre Biron, Jacques Trudel, C Dufault, J Genest
PMCID: PMC1938705  PMID: 14432939

Full text

PDF
690

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CASS R., KUNTZMAN R., BRODIE B. B. Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med. 1960 Apr;103:871–872. doi: 10.3181/00379727-103-25702. [DOI] [PubMed] [Google Scholar]
  2. MAXWELL R. A., MULL R. P., PLUMMER A. J. [2-Octahydro-1-azocinyl)-ethyl]-guanidine sulfate (CIBA 5864-SU), a new synthetic antithypertensive agents]. Experientia. 1959 Jul 15;15:267–267. doi: 10.1007/BF02158076. [DOI] [PubMed] [Google Scholar]
  3. MAXWELL R. A., PLUMMER A. J., SCHNEIDER F., POVALSKI H., DANIEL A. I. Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864). J Pharmacol Exp Ther. 1960 Jan;128:22–29. [PubMed] [Google Scholar]
  4. MAXWELL R. A., ROSS S. D., PLUMMER A. J. Pharmacology of hexahydro-1-azepinepropionamidoxime dihydrochloride (SU-4029). J Pharmacol Exp Ther. 1958 Jun;123(2):128–139. [PubMed] [Google Scholar]
  5. PAGE I. H., DUSTAN H. P. A new, potent antihypertensive drug: preliminary study of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (guanethidine). J Am Med Assoc. 1959 Jul 11;170(11):1265–1271. doi: 10.1001/jama.1959.03010110013003. [DOI] [PubMed] [Google Scholar]
  6. RICHARDSON D. W., WYSO E. M. Effective reduction in blood pressure without ganglionic blockade. Va Med Mon (1918) 1959 Jul;86(7):377–381. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES